FDA Approves Pomalidomide for Patients with AIDS-Related Kaposi Sarcoma

Pomalidomide was approved for patients with AIDS-related Kaposi sarcoma whose disease has become resistant to highly active antiretroviral therapy, or in patients with Kaposi sarcoma who are HIV-negative.

Tavo, Pembrolizumab Combo May Aid in Reducing Remissions in Advanced Melanoma

The combination of tavo and pembrolizumab was associated with a higher than anticipated response rate in patients with advanced melanoma with low frequencies of checkpoint positive cytotoxic lymphocytes.

Christopher R. Flowers, MD, on Disparities in Lymphoma and Myeloma

The lymphoma and myeloma expert indicated that one of the key ways to address these disparities in lymphoma and myeloma is to improve minority and rural accrual in clinical trials.